Amit Bansal
342 IP cases indexed. Covers trademark, patent matters.
Cases Presided Over
342 cases indexed | Page 9 of 12
Charanjiv Kumar Taneja Trading As Chirag Enterprises v.The Registrar Of Trade Marks
The Delhi High Court dismissed a writ petition filed by Charanjiv Kumar Taneja Trading As Chirag Enterprises, which sought to restore a lapsed trademark registration. The petitioner had failed to renew their 'TIGER' mark after 2006 and only attempted renewal in 2022, sixteen years later. The court held that the petitioner could not take advantage of such undue delay, especially since the RTI response confirmed an O3 notice was generated in 2006 but remained untraceable.
Mankind Pharma Limited v.Arvind Kumar Trading And Anr.
The Delhi High Court allowed Mankind Pharma Limited's petition seeking the removal of the trademark 'NIKIND'. The court found that 'NIKIND' was confusingly similar to the petitioner's established family of marks, including 'NIMEKIND', and that its registration should be cancelled under Section 57 of the Trademarks Act. Furthermore, the judgment noted a lack of bonafide use and continuous non-use of the impugned mark for five years, leading to its removal under Section 47.
Usha International Limited v.Registrar Of Trademarks And Anr.
Usha International Limited filed a petition seeking the removal/cancellation of the mark 'WSHA' from the Trade Marks Register, arguing that it is deceptively similar to their long-standing mark 'USHA'. The Delhi High Court accepted the petition and issued notice to the respondents. The matter was subsequently listed for further arguments on April 4, 2022.
Arena Pharmaceuticals, Inc. v.The Assistant Controller Of Patents And Designs
Arena Pharmaceuticals filed an appeal against the Assistant Controller's order rejecting its patent application. The appellant argued that certain grounds for rejection were not addressed during the hearing notice and pointed out inconsistencies within the rejection order.
Jagran Prakashan Ltd v.Jagran Production Ltd & Anr
The Delhi High Court addressed multiple connected suits involving Jagran Prakashan Ltd against various related entities concerning the use of the 'JAGRAN' trademark. The court noted significant changes, including a company name change and another entity being under liquidation. Given the lack of compliance with previous orders regarding business operations, the court granted an extended deadline for defendants to file affidavits detailing their current business activities. Furthermore, the parties were directed to explore mediation as a potential resolution pathway.
Bayona Spa v.Varun Exports & Ors.
The Delhi High Court disposed of a petition concerning a trademark dispute between Bayona Spa and Varun Exports & Ors. The court noted that the respondents had filed an application to withdraw the impugned mark before the Trademarks Registry. Consequently, the petitioner's relief was deemed infructuous, leading the court to issue directions for the Registrar of Trademarks to cancel the registration No. 4188398 in class 25.
Akzo Nobel Coatings International B.V. v.Ambience Limited And Anr
The Delhi High Court addressed a trademark dispute concerning the identical mark 'AMBIANCE'. After considering arguments regarding co-existence under Section 12 of the Trade Marks Act, 1999, the court ruled in favor of Akzo Nobel Coatings International B.V. The judgment directs the Registry not to consider Ambience Limited's existing application for 'AMBIANCE' in Class 02 when evaluating the petitioner's applications, thereby allowing both parties to use the mark concurrently on the register.
Virendra Kumar Gupta v.Burger King Corporation
The Madras High Court dismissed a rectification petition filed by Virendra Kumar Gupta against Burger King Corporation. The petitioner sought to cancel or impose a disclaimer on the 'Burger' and 'King' marks registered under No. 927122. The court relied on prior judgments, including one from the Delhi High Court and the Supreme Court ruling in Patel Field Marshal Agencies vs P.M. Diesels Ltd., concluding that the petition was not maintainable.
Puma Se v.Naveen Sikka And Anr
The Delhi High Court allowed Puma Se's petition to cancel a specific trademark registered by Naveen Sikka and Anr. The judgment followed a settlement agreement reached between the parties, which was found to be lawful. Consequently, the court ordered the removal of the impugned mark from the Register of Trade Marks in Class 9.
Boehringer Ingelheim Pharma Gmbh & Co. v.Vee Excel Drugs And Pharmaceuticals Private Ltd.
Boehringer Ingelheim Pharma filed multiple suits seeking permanent injunction against generic drug manufacturers, including Vee Excel Drugs, alleging infringement of Indian Patent No. IN 243301 related to Linagliptin compounds. The Delhi High Court examined the applications for interim injunction across all connected matters. The court found that the patent was vulnerable to revocation due to prior claiming and noted attempts at evergreening by the patentees. Consequently, the plaintiffs failed to establish a prima facie case, leading to the dismissal of all interim injunction applications.
Boehringer Ingelheim Pharma Gmbh & Co. v.Vee Excel Drugs And Pharmaceuticals Private Ltd.
This judgment addresses multiple suits filed by Boehringer Ingelheim Pharma against various Indian pharmaceutical companies, seeking permanent injunctions against infringing Patent No. IN 243301 related to Linagliptin tablets. The Delhi High Court examined the prima facie case and found that the patent was vulnerable to revocation due to prior claiming and attempts at evergreening by the plaintiffs. Consequently, the court dismissed all applications for interim injunction, allowing defendants to manufacture and sell products containing Linagliptin as the active pharmaceutical ingredient.
Boehringer Ingelheim Pharma Gmbh And Co. Kg & Anr. v.Vee Excel Drugs and Pharmaceuticals Private Ltd. & Ors., Alkem Laboratories Ltd & Anr., Micro Labs Limited, Natco Pharma Limited & Anr., Mankind Pharma Limited
Boehringer Ingelheim Pharma sought permanent injunctions against various Indian pharmaceutical companies, alleging infringement of Patent No. IN 243301 related to Linagliptin tablets. The Delhi High Court examined the applications for interim injunction across multiple connected suits. The court found that the plaintiffs failed to establish a prima facie case, noting concerns about potential patent vulnerability due to prior claiming and attempts at evergreening. Consequently, all interim injunction applications were dismissed, allowing defendants to continue manufacturing and selling the products.
Boehringer Ingelheim Pharma Gmbh And Co. Kg & Anr. v.Mankind Pharma Limited
Boehringer Ingelheim Pharma filed multiple suits seeking permanent injunction against Indian pharmaceutical companies for allegedly infringing Patent No. IN 243301, which covers Linagliptin compounds. The Delhi High Court examined the applications for interim injunction across all connected matters. The court found that the suit patent was vulnerable to revocation due to prior claiming and noted attempts by the plaintiffs towards 'evergreening.' Consequently, the court dismissed all applications for interim injunction, allowing defendants to manufacture and sell products containing Linagliptin.
Boehringer Ingelheim Pharma Gmbh And Co. Kg & Anr. v.Alkem Laboratories Ltd & Anr., Vee Excel Drugs and Pharmaceuticals Private Ltd. & Ors., Micro Labs Limited, Natco Pharma Limited & Anr., Mankind Pharma Limited
This judgment addresses multiple suits filed by Boehringer Ingelheim Pharma against various Indian pharmaceutical companies seeking permanent injunctions for infringing Patent No. IN 243301, which covers Linagliptin compounds. The Delhi High Court found that the plaintiffs failed to establish a prima facie case for granting interim relief. Furthermore, the court expressed concern regarding the patent's vulnerability due to prior claiming and alleged attempts at 'evergreening.' Consequently, all applications for injunction were dismissed, allowing defendants to continue manufacturing and selling products containing Linagliptin.
Khadi And Village Industries Commission v.Meet Dilipkumar Patel And Anr.
The Delhi High Court confirmed the existing ad-interim injunction restraining the defendants from using the 'KHADI ARK' and similar marks, maintaining the status quo during the ongoing suit. While the court upheld the protection of the plaintiff's trademark rights, discussions opened regarding a potential settlement, with the defendant offering an undertaking not to use the trademarks in the future if damages were waived. The matter was adjourned for further resolution.
Boehringer Ingelheim Pharma Gmbh And Co. Kg & Anr. v.Vee Excel Drugs and Pharmaceuticals Private Ltd. & Ors., Alkem Laboratories Ltd & Anr., Micro Labs Limited, Natco Pharma Limited & Anr., Mankind Pharma Limited
This judgment addresses multiple suits filed by Boehringer Ingelheim Pharma seeking permanent injunction against various Indian pharmaceutical companies for infringing Patent No. IN 243301, which covers Linagliptin compounds. The court examined the applications for interim injunction and found that the plaintiffs failed to establish a prima facie case. Furthermore, the judge expressed concerns regarding the patent's vulnerability due to prior claiming and alleged attempts at evergreening by the patentees. Consequently, all interim injunction applications were dismissed, allowing the defendants to continue manufacturing and selling products containing Linagliptin.
Dinesh Kumar Mittal M/S Paras Enterprises v.Pragya Trading Company, Kaserate
In this trademark dispute, the Delhi High Court issued an order directing the removal of the impugned mark from the Trademark Register. The court noted that despite the petitioner's claims, the registration had expired on February 21, 2022, and the statutory one-year period for restoration under Section 25(4) of the Trade Marks Act, 1999, had lapsed without any renewal application being filed. While this order addresses the validity status of the mark, it explicitly leaves all merits of the dispute open for future consideration.
Alternative Gene Expression S L v.The Controller Of Patents
The appellant challenged the Patent Office's order rejecting its patent application, which held that the method of producing recombinant proteins by destruction of pupa was non-patentable under Section 3(b). The High Court found the rejection order to be cryptic and lacking reasoned justification despite detailed submissions from the appellant.
Loreal India Pvt Ltd v.Rajesh Kumar Taneja Trading As Innovative Derma Care and Anr
The Delhi High Court dismissed an appeal filed by Loreal India Pvt Ltd seeking the cancellation of the trademark 'CLARIWASH' registered in favor of Rajesh Kumar Taneja. Loreal argued that its predecessor used formative marks like 'CLARI-FI' and 'CLARIMOIST' prior to the registration, claiming deceptive similarity and prior use. However, the Court found no grounds to interfere with the original judgment, noting that the application was filed over 14 years ago and procedural errors alone were insufficient basis for cancellation.
Sun Pharma Laboratories Ltd v.Nuberg Pharmaceuticals Pvt. Ltd.
Sun Pharma and Nuberg Pharmaceuticals reached a full settlement in their commercial IP dispute before the Delhi High Court. The court formally decreed the suit based on the agreed-upon terms, which included significant concessions from both parties. Furthermore, the judgment mandated that Respondent No. 2 remove a specific trademark entry (No. 3797651) from the Register of Trademarks within six weeks.
Alpha Corp Development Private Limited v.Alpha Integrated Management Services Pvt. Ltd.
The Delhi High Court allowed a rectification petition filed by Alpha Corp Development Private Limited against a deceptively similar trademark registered by its former employees' company, Alpha Integrated Management Services Pvt. Ltd. The court found that the impugned mark was identical and confusingly similar to the petitioner's established 'ALPHA' brand in real estate services. Given the respondent's dishonest adoption of the mark to ride on the petitioner's goodwill, the High Court ordered the cancellation of the infringing trademark registration.
Pandrol Limited & Anr. v.Patil Rail Infrastructure Pvt. Ltd. & Others
The Delhi High Court granted several interim reliefs in favor of Pandrol Limited, who filed a suit alleging infringement of its copyright and trademark. The court exempted the plaintiffs from pre-litigation mediation due to the urgency of the matter. Crucially, the court allowed an ex-parte ad-interim injunction by appointing a Local Commissioner with broad powers to seize infringing products and gather evidence from the defendants' premises.
Tapas Chatterjee v.Assistant Controller Of Patents And Designs & Anr.
The appellant challenged the refusal of their Indian Patent Application No. 201911036748 by the Controller on grounds of non-patentability under Section 3(d) and lack of inventive step. The appeal argued that the invention was novel, inventive, and not subject to the bar of Section 3(d). However, the High Court upheld the Controller's refusal.
Dorco Co Ltd v.Durga Enterprises And Anr
The Delhi High Court allowed a rectification petition filed by Dorco Co Ltd against Durga Enterprises And Anr, successfully removing the infringing 'DORCO' trademark (Registration No. 1252224) from the register. The court found that the respondent failed to demonstrate genuine use of the mark for five years and that its registration was obtained dishonestly to ride on Dorco’s established goodwill. This ruling reinforces the principle that trademarks must be used genuinely, and prior users with strong reputation have superior rights.
Vinod Aggarwal Trading As Vaneet Sales Corporation v.Meera Devi & Anr.
The Delhi High Court allowed a civil original trademark rectification petition filed by Vinod Aggarwal Trading As Vaneet Sales Corporation against Meera Devi. The court found that the respondent's adoption and use of the similar mark 'BAL BIHARI SUPER' was dishonest, as it followed an earlier acknowledgment of the petitioner's rights by her husband. Given the identical nature of the goods (tobacco products) and the likelihood of consumer confusion, the court ordered the removal of the impugned trademark from the Register.
Burger King Company Llc v.Ranjan Gupta & Ors.
The Delhi High Court affirmed the strong standing of Burger King Company LLC, declaring its trademark 'BURGER KING' to be well-known in India. The court relied on extensive global usage, massive promotional investment, and local market presence (over 400 outlets) to establish secondary meaning. This ruling significantly strengthens the brand's protection against unauthorized use by defendants operating under similar names like 'Burger King Family Restaurant'.
Sns Products Private Limited v.Ijazuddin
The Delhi High Court disposed of a commercial suit (CS(COMM) 34/2022) in favor of Sns Products Private Limited. The defendant, Ijazuddin, agreed to permanent injunctive relief for the plaintiff and consented to transferring all relevant trademark and copyright applications to the plaintiff. Consequently, the court passed a decree based on these terms, resolving the dispute.
Vinay Aggarwal v.Rims Marketing Pvt. Ltd.
The Delhi High Court confirmed an existing interim injunction, ruling in favor of the plaintiff regarding passing off. The court found that the defendant's use of 'ELEPHANT JINLI' was phonetically and structurally similar to the plaintiff's established mark 'ELEPHANT,' creating a likelihood of confusion among consumers. Despite arguments regarding conflicting agreements from the manufacturer, the court upheld the plaintiff's prior rights and dismissed the defendant's application to vacate the injunction.
Pidilite Industries Limited v.Mr. X, Trading As, M/S Prabhat Store
In a trademark infringement case concerning Pidilite Industries Limited's products (FEWIKWIK and M-SEAL), the Delhi High Court granted an extension for its local commissioners. The court allowed the plaintiff to continue seizing counterfeit goods based on new market evidence, ensuring that enforcement actions could proceed until the next hearing date. This order maintains the status quo regarding anti-counterfeiting measures while allowing defendants time to prepare their defense.
Ozone Overseas Private Limited v.Sukkhjinder Singh Virdi & Ors.
The Delhi High Court framed issues in the suit filed by Ozone Overseas Private Limited against Sukhkjinder Singh Virdi & Ors. The litigation involves multiple IP claims, including infringement of the registered trademark OZONE/OZONE DEVICE and copyright infringement related to product catalogues and logos. Furthermore, the plaintiff has alleged passing off due to the defendants' use of near-identical materials. This order sets the stage for a full trial addressing territorial jurisdiction, ownership rights, and damages.
Facing a similar IP matter?
Arctic Invent is a specialist IP firm with deep litigation expertise across India, EU, US, and UK. Our team uses data-driven strategy to build stronger cases.